未登录

N

Núria Pérez-Álvarez

hospital germans triasi pujol

H指数:30

被引数:2,696

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection

SCIENTIFIC REPORTS

IF3.9

2021-05-289

OAAI

Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2020-11-217

OAAI

Potential prescribing issues among older HIV-infected subjects in a Mediterranean cohort: Does the current prevalence give cause for concern?

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2020-10-1611

OAAI

Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study) (vol 11, pg 65, 2019)

ECLINICALMEDICINE

IF10

2020-01-010

OAAI

Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study)

ECLINICALMEDICINE

IF10

2019-05-0151

OAAI

NEU Screen Shows High Accuracy in Detecting Cognitive Impairment in Older Persons Living With HIV

JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE

IF1.5

2019-01-015

PREAI

Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2017-03-227

OAAI

Withdrawing inactive NRTIs in HIV-1 subjects with suppressed viraemia: a randomized trial

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2016-01-234

OAAI

Disability-adjusted-life-years losses in postmenopausal women with osteoporosis: a burden of illness study

BMC PUBLIC HEALTH

IF3.6

2015-04-0232

OAAI

Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2015-03-1323

OAAI

High Prevalence of Signs of Renal Damage Despite Normal Renal Function in a Cohort of HIV-Infected Patients: Evaluation of Associated Factors

AIDS PATIENT CARE AND STDS

IF3.8

2014-10-0118

OAAI

Classification Models for Neurocognitive Impairment in HIV Infection Based on Demographic and Clinical Variables

IF2.6

2014-09-1920

OAAI

Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study)

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2014-08-1341

OAAI

A Brief and Feasible Paper-Based Method to Screen for Neurocognitive Impairment in HIV-Infected Patients: The NEU Screen

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

IF2.2

2013-08-1523

PREAI

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2013-05-1430

OAAI

Long-term effectiveness of infrared coagulation for the treatment of anal intraepithelial neoplasia grades 2 and 3 in HIV-infected men and women

IF3.1

2013-03-2730

OAAI

Switching the third drug of antiretroviral therapy to maraviroc in aviraemic subjects: a pilot, prospective, randomized clinical trial

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2013-01-2523

OAAI

Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery

IF3.1

2012-11-2843

OA

DISABILITY-ADJUSTED-LIFE-YEARS (DALYS) LOSS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS

VALUE IN HEALTH

IF6

2012-11-010

OAAI

Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment

心理压力与接受有效联合抗逆转录病毒治疗的HIV-1感染者的高水平IL-6有关

BRAIN BEHAVIOR AND IMMUNITY

IF7.6

2012-05-0137

PREAI